CN Patent

CN117342993A — 一种曲法罗汀盐及其药物组合物和用途

Assigned to Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd · Expires 2024-01-05 · 2y expired

What this patent protects

本发明公开了一种曲法罗汀盐及其药物组合物和用途。所述曲法罗汀盐如式(I 0 )所示，取代基的定义详见说明书；该盐可用于制备通过调节视黄醇受体(RAR)来介导视黄醇的生物效应治疗疾病的药物。

USPTO Abstract

本发明公开了一种曲法罗汀盐及其药物组合物和用途。所述曲法罗汀盐如式(I 0 )所示，取代基的定义详见说明书；该盐可用于制备通过调节视黄醇受体(RAR)来介导视黄醇的生物效应治疗疾病的药物。

Drugs covered by this patent

Patent Metadata

Patent number
CN117342993A
Jurisdiction
CN
Classification
—
Expires
2024-01-05
Drug substance claim
No
Drug product claim
No
Assignee
Shijiazhuang Dikaiwei Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.